PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Wednesday reported a loss of $26.2 million in its fourth quarter.
On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 36 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The drugmaker posted revenue of $8.5 million in the period.
For the year, the company reported that its loss widened to $73.7 million, or $1.01 per share. Revenue was reported as $35.4 million.
Inovio shares have decreased 1 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.87, an increase of 5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INO at https://www.zacks.com/ap/INO
Keywords: Inovio Pharmaceuticals, Earnings Report